Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination

Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination
A syringe inserted into a COVID-19 vaccine vial. Robert Avgustin/Shutterstock
|Updated:
0:00

Emergent peer-reviewed studies have highlighted the occurrence of neuromyelitis optica after COVID-19 vaccinations, suggesting that the autoimmune disease may be occurring as a vaccine adverse event.

The studies’ general findings indicate an occurrence of neuromyelitis optica (NMO) in healthy individuals within around two weeks after Pfizer, Moderna, and AstraZeneca vaccines. In patients already affected by the disease or a similar neurological autoimmune disease such as multiple sclerosis, an exacerbation of symptoms or relapse was observed.
Marina Zhang
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times, based in New York. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].
Related Topics